Get the app
US › Healthcare

HCA Healthcare, Inc. (HCA)

US · Healthcare · Medical Care Facilities

$494.99-2.46%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$19.85B
Revenue YoY
+3.6%
Net profit
$1.58B
Profit YoY
-3.9%
EPS
$7.22
EPS estimate
$6.74
Net margin
8.0%

EPS came in at 7.22 against a street estimate of 6.74 — a beat of 7.1%.

Key statistics

Market cap
$106.68B
P/E
15.4
Forward P/E
14.8
P/B
291.34
Book value
$-38.30
EPS (TTM)
$33.27
Dividend yield
0.66%
52-week high
$553.56
52-week low
$353.34
50-day MA
$438.86
200-day MA
$444.28
Beta
1.10

Analyst view

Analysts rate HCA Healthcare, Inc. a buy (15 buy, 9 hold, 2 sell out of 26) with an average price target of $475.45.

From the latest earnings call · 2026-10-27

MIXED HCA delivered solid volume and cost performance, but exchange-related payer disruption remains significant. Management expects 2027 earnings generally consistent with 2026. Q3 FY26 Regional performance was not quantified. Analysts focused on exchange disruption, surgery demand, supplemental payments and cost savings. Management emphasized uncertainty but cited resilient core demand and ongoing cost initiatives. 2026-10-27…

Full summary in the app.

Shareholding

Insiders
17.22%
Institutions
81.41%

Largest institutional holders

FundStake
BlackRock Inc6.22%
Vanguard Capital Management, LLC4.86%
Sanders Capital, LLC4.23%
State Street Corp3.58%
Arnhold & S. Bleichroeder Advisers, LLC3.16%
Wellington Management Company LLP2.25%
Geode Capital Management, LLC1.76%
Vanguard Portfolio Management, LLC1.30%

Recent filings & reports

DocumentDate
Material agreement · Q4 2026
HEADLINE NUMBERS • HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering totaling $6,500,000,000 in senior notes on Nove
2026-11-05
Company announcement · Q4 2026
HEADLINE NUMBERS • HCA Healthcare announced a proposed public offering of senior unsecured notes through HCA Inc., its direct, wholly owned subsidiar
2026-11-02
Quarterly report · Q3 2026
HEADLINE NUMBERS • For the quarter ended September 30, 2026, revenue was $19,849 million, up from $19,161 million in 2025. • Net income attributable
2026-10-29
Results announced · Q4 2026
HEADLINE NUMBERS • Third-quarter revenue increased 3.6% to $19.849 billion from $19.161 billion. • Net income attributable to HCA Healthcare, Inc. d
2026-10-27
Company announcement · Q3 2026
HCA HEALTHCARE, INC. - 8-K SUMMARY HEADLINE NUMBERS • Commercial paper program maximum capacity increased from $4.0 billion to $8.0 billion • Increa
2026-07-29
Quarterly report · Q2 2026
HCA HEALTHCARE, INC. - 10-Q SUMMARY For Quarter and Six Months Ended June 30, 2026 --- HEADLINE NUMBERS • Q2 2026 Revenue: $20,230 million vs. Q2 2
2026-07-28
Results announced · Q3 2026
HCA HEALTHCARE Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Revenues: $20.230 billion in Q2 2026, up 8.7% vs Q2 2025 ($18.605 billion) • Net income at
2026-07-24
Results announced · Q3 2026
HCA HEALTHCARE Q2 2026 PRELIMINARY RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 Revenues: $20.230 billion vs. $18.605 billion in Q2 2025 (+8.7% year-o
2026-07-14

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.78 / share
ex-date Dec 15, 2026 · pay Dec 29, 2026
2026-12-15
Dividend$0.78 / share
ex-date Sep 16, 2026 · pay Sep 30, 2026
2026-09-16
Dividend$0.78 / share
ex-date Jun 16, 2026 · pay Jun 30, 2026
2026-06-16
Dividend$0.78 / share
ex-date Mar 17, 2026 · pay Mar 31, 2026
2026-03-17
Dividend$0.72 / share
ex-date Dec 15, 2025 · pay Dec 29, 2025
2025-12-15

Deals & corporate news

AnnouncementDate
Q2 2026 results with updated guidance and key assumptions
HCA Healthcare reported Q2 2026 results with mixed performance. Revenues grew 8.7% to $20.2 billion, and diluted EPS increased 11.6% to $7.62. However, net income growth was modest at only 2
2026-07-24
Previews Q2 2026 results and revises full year 2026 guidance
HCA Healthcare reported Q2 2026 preliminary results showing revenue growth to $20.23 billion (vs. $18.61 billion YoY) and net income of $1.70 billion ($7.62 per share vs. $6.83 YoY). However
2026-07-14
Fourth quarter 2025 results reported and 2026 guidance provided
HCA Healthcare reported strong fourth-quarter 2025 results with significant growth across key metrics. Revenues grew 6.7% to $19.513 billion, while net income jumped 30.6% to $1.878 billion.
2026-01-27

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for HCA Healthcare, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.